Radioprotective agents
OwnerAlla Shapiroinventor
Life of this patent
Estimating the term…
Abstract
A non-toxic and effective isoflavone radioprotective agent for treating or preventing effects and damage due to radiation exposure, or increasing the survivability to a lethal dose of radiation. The isoflavone can be administered orally, subcutaneously, intramuscularly, intravenously, transdermally, intranasally, or rectally. The isoflavone is administered chronically, and/or before, during and/or after radiation exposure. These radioprotective agents can be used to protect personnel exposed to radioactive substances.
Claims28
A method of treating or preventing the effects of radiation in a mammal exposed to radiation, said method comprising administering to said mammal a therapeutically effective amount of an isoflavone.
A method of treating or preventing damage to living cells, tissues and organs caused by exposure to radiation, said method comprising administering to a therapeutically effective amount of an isoflavone.
A method of protecting personnel exposed to radioactive substances, said method comprising administering to said personnel a therapeutically effective amount of an isoflavone.
A method for increasing survivability of mammals from a lethal dose of radiation, said method comprising administering to said mammal before, during and/or after said lethal dose of radiation a therapeutically effective amount of a compound of the formula:
- 2
- wherein R1, R2 and R3 are independently selected from the group consisting of hydrogen, hydroxyl and alkoxy.
Dependencies are inferred from the claim text.